The blockbuster GLP-1 drugs that have reshaped the treatment of diabetes and obesity may help prevent multiple substance use disorders — and reduce the tragic outcomes they cause, a large new study finds. An analysis published Wednesday in a medical journal looked
New Delhi, November 21, 2023 (Mirror) In India, around 10.1 crore people are living with diabetes. A whopping 13.6 crore more people are at high risk of developing type 2 diabetes (pre-diabetes), according to a recently published study by the Madras Diabetes
By Alisha Haridasani Gupta (New York Times), November 22, 2023: Across the U.S., roughly 6 million adults 65 and over have Alzheimer’s disease. Almost two thirds of them are women — a discrepancy that researchers have long attributed to genetics and women’s
New Delhi, November 21, 2023 (Mirror) As we approach the winter months, it might feel like catching some form of illness is inevitable. Whether it’s the common cold, the flu, or Covid, our vulnerability to infections increases during this time of year.
New Delhi, November 20, 2023: Only one injection every six months that “switches off” high blood pressure could soon consign daily pills to history. A single dose of the drug, called zilebesiran, can control the condition for up to six months, with
